Tumor Cell Resistance

 

WHOLE BODY & LOCAL HYPERTHERMIA



Hyperthermia has shown to be effective in almost all cancer modalities. It can also be combined with other cancer therapies. The effects and scientific evidence of hyperthermia are thermo sensitivity of tumor tissue, especially at decreased PH and pO2.

It increases the cellular metabolic rate, breaking down glucose to lactic acid and thus decreasing pH to very low levels. High acidity and hypoxemia also damage the vessels that nourish tumor cells, thus choking them off from blood supply. High temperatures kill cancer cells and increases potent effects of herbal and nutritional anti-cancer therapies.

It also damages the membranes, proteins, and enzymes of cancer cells making them more sensitive to other therapies.

Immunological and biological effects due to heat are accelerated emigration and migration of peripheral blood mononuclear cells, activation of effecter cells, induction and secretion cytokines, and expression of heat shock proteins (HSP) which increases the antigenicity of cancer cells.

During the hyperthermia procedure, the patient is under mild sedation, continuously monitored with O2 saturation, blood pressure, pulse, ecg, and temperature. With the use of thermal probes, the information provided feeds back to the computer that controls the heat exchange unit.

In a routine treatment protocol, temperature will be raised to a constant plateau that lasts 60 to 90 minutes at a temperature of 42 C degrees (108 F). Constant medical and nursing surveillance makes the procedure a safe and reliable therapeutic tool.

Hyperthermia indications:
  • For patients with isolated metastasis
  • Adjuvant treatment in oncology
  • Malignant Lymphomas
  • Immunological efficiency against tumor cells
  • Thermal regulation, often disrupted by cancer, can be unblocked.
  • Infectious disease.
  • Chronic viral infectious.
  • Hepatitis C.

DENDRITIC CELLS

Dendritic Cells are bone-marrow-derived professional antigen presenting cells.
Dc‘s have the ability to induce primary T-cell-dependent immune responses in vivo and in vitro.
This unique feature gives dendritic cells a central role in controlling immunity.

DC‘s are potent antigen presenting cells (APCs) that possess the ability to stimulate na´ve T-cells. They comprise a system of leukocytes widely distributed in all tissues, especially in those that provide an environmental interface.

 

Dendritic Cells

IPT THERAPY

It is an effective and powerful treatment for cancer, using insulin to increase the cancer killing effects of chemotherapy. Because of this potentiating effect, lower doses of chemotherapy are used, making it a much safer option than traditional methods in the treatment of cancer.

IPT Therapy